Invivyd, Inc. Files 8-K for Material Agreement
Ticker: IVVD · Form: 8-K · Filed: Apr 21, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | Apr 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, 8-k
TL;DR
Invivyd inked a big deal and took on debt, filing an 8-K on 4/18.
AI Summary
Invivyd, Inc. announced on April 18, 2025, the entry into a material definitive agreement and the creation of a direct financial obligation. The company, formerly known as Adagio Therapeutics, Inc., filed an 8-K report detailing these events. The filing does not specify the nature of the agreement or the financial obligation.
Why It Matters
This filing indicates Invivyd has entered into a significant agreement and incurred a financial obligation, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement and a direct financial obligation, which inherently carries financial risk for the company.
Key Numbers
- 001-40703 — SEC File Number (Identifies the company's filing history with the SEC.)
- 85-1403134 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former Company Name
- April 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Waltham, MA (location) — Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by Invivyd, Inc.?
The filing does not specify the details of the material definitive agreement.
What is the direct financial obligation incurred by Invivyd, Inc.?
The filing states the creation of a direct financial obligation but does not provide specific details about its nature or amount.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 18, 2025.
What was Invivyd, Inc.'s former company name?
Invivyd, Inc.'s former company name was Adagio Therapeutics, Inc.
Where are Invivyd, Inc.'s principal executive offices located?
Invivyd, Inc.'s principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding Invivyd, Inc. (IVVD).